Schmid, P.Salvador Bofill, J.Bermejo, B.Phillips, M.Wheatley, D.Neus, F.Schem, C.Stradella, A.Mele, M.Cortes Salgado, A.Quiroga, V.Anton Torres, A.Llombart Cussac, A.Zamora, E.Viale, G.Kuemmel, S.Prendergast, A.Mousa, K.Gluz, O.Cortes, J.2025-01-072025-01-072021-09-210923-7534https://hdl.handle.net/10668/27174enBARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancerconference outputopen access10.1016/j.annonc.2021.08.4041569-8041https://doi.org/10.1016/j.annonc.2021.08.404700527700124